Center for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, United States; Department of Medicine and of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States
Anisa Azatovna Gumerova
Center for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, United States; Department of Medicine and of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States
Ronit Witztum
Center for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, United States; Department of Medicine and of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States
Funda Korkmaz
Center for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, United States; Department of Medicine and of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States
Liam Cullen
Center for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, United States; Department of Medicine and of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States
Hasni Kannangara
Center for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, United States; Department of Medicine and of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States
Ofer Moldavski
Center for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, United States; Department of Medicine and of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States
Orly Barak
Center for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, United States; Department of Medicine and of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States
Daria Lizneva
Center for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, United States; Department of Medicine and of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States
Center for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, United States; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, United States
Sarah Stanley
Department of Medicine and of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States
Se-Min Kim
Center for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, United States; Department of Medicine and of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States
Tony Yuen
Center for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, United States; Department of Medicine and of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States
Center for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, United States; Department of Medicine and of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States
There is clear evidence that the sympathetic nervous system (SNS) mediates bone metabolism. Histological studies show abundant SNS innervation of the periosteum and bone marrow–these nerves consist of noradrenergic fibers that immunostain for tyrosine hydroxylase, dopamine beta-hydroxylase, or neuropeptide Y. Nonetheless, the brain sites that send efferent SNS outflow to the bone have not yet been characterized. Using pseudorabies (PRV) viral transneuronal tracing, we report, for the first time, the identification of central SNS outflow sites that innervate bone. We find that the central SNS outflow to bone originates from 87 brain nuclei, sub-nuclei, and regions of six brain divisions, namely the midbrain and pons, hypothalamus, hindbrain medulla, forebrain, cerebral cortex, and thalamus. We also find that certain sites, such as the raphe magnus (RMg) of the medulla and periaqueductal gray (PAG) of the midbrain, display greater degrees of PRV152 infection, suggesting that there is considerable site-specific variation in the levels of central SNS outflow to the bone. This comprehensive compendium illustrating the central coding and control of SNS efferent signals to bone should allow for a greater understanding of the neural regulation of bone metabolism, and importantly and of clinical relevance, mechanisms for central bone pain.